Cargando…
Access to the CNS: Biomarker Strategies for Dopaminergic Treatments
Despite substantial research carried out over the last decades, it remains difficult to understand the wide range of pharmacological effects of dopaminergic agents. The dopaminergic system is involved in several neurological disorders, such as Parkinson’s disease and schizophrenia. This complex syst...
Autores principales: | van den Brink, Willem Johan, Palic, Semra, Köhler, Isabelle, de Lange, Elizabeth Cunera Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814527/ https://www.ncbi.nlm.nih.gov/pubmed/29450650 http://dx.doi.org/10.1007/s11095-017-2333-x |
Ejemplares similares
-
Analytical strategies for discovery and replication of genetic effects in pharmacogenomic studies
por: Kohler, Jared R, et al.
Publicado: (2014) -
Challenges and Strategies for Improving Access to Cancer Drugs in Malaysia: Summary of Opinions Expressed at the 2nd MACR International Scientific Conference 2022
por: Tan, Shing Cheng, et al.
Publicado: (2023) -
Fingerprints of CNS drug effects: a plasma neuroendocrine reflection of D
(2) receptor activation using multi‐biomarker pharmacokinetic/pharmacodynamic modelling
por: van den Brink, Willem J, et al.
Publicado: (2018) -
Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service Delivery
por: Amoaku, Winfried, et al.
Publicado: (2020) -
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
por: Adepoju, Victor A.
Publicado: (2019)